Successful use of problem-solving methodology to reduce pharmacy chemotherapy processing time
Journal of the American Pharmacists Association : Japha
|August 22, 2020
Summary
A new Concierge initiative significantly reduced pharmacy turnaround time and patient wait times for chemotherapy services. This approach improved workflow and capacity, allowing more patients to be treated daily without compromising safety or quality.
Area of Science:
- Pharmacy Practice
- Healthcare Operations
- Quality Improvement
Background:
- Hospital pharmacies face challenges with high compounded chemotherapy order volumes, leading to staff overload during peak hours.
- This overload contributes significantly to extended patient wait times and impacts overall pharmacy turnaround time (TAT).
Purpose of the Study:
- To reduce pharmacy turnaround time (TAT) and compounding order overload during peak hours.
- To decrease patient wait times for pharmacy services without compromising safety and quality.
Main Methods:
- Implementation of a "Concierge" initiative involving advanced preparation of chemotherapy for select patients.
- Utilized Define Measure Analyze Improve Control (DMAIC) Six Sigma methodology and intelligent risk-taking strategies to identify and address root causes.
Main Results:
- Pharmacy TAT decreased by 77% for Concierge patients and 31% for standard patients.
- Patient wait time decreased by 67% for Concierge patients and 27% for standard patients.
- Observed an 8% increase in patient capacity despite no changes in physical infrastructure.
Conclusions:
- The Concierge initiative markedly reduced pharmacy TAT and patient wait times, particularly for chemotherapy services.
- Improved workflow efficiency and staff assignment distribution, leading to decreased order overload and enhanced patient throughput.
- Successfully maintained safety and quality standards while increasing the number of patients treated daily.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
319
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
319
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
88
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
88


